SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-401787
Filing Date
2015-12-14
Accepted
2015-12-11 21:57:00
Documents
3
Period of Report
2015-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d105019d6k.htm 6-K 12928
2 EX-4.1 REGISTRATION RIGHTS AGREEMENT d105019dex41.htm EX-4.1 61422
3 EX-4.2 FIRST AMENDMENT TO REGISTRATION RIGHTS AGREEMENT d105019dex42.htm EX-4.2 22898
  Complete submission text file 0001193125-15-401787.txt   98221
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 151284453
SIC: 2834 Pharmaceutical Preparations